Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
218 studies found for:    Pituitary Tumors
Show Display Options
Download search resultsDownload the search results for:
Pituitary Tumors (218 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Unknown  Pituitary Tumor Surveillance: Pathogenic Correlation
Condition: Pituitary Tumor
Intervention:
2 Recruiting Ga-68-DOTATOC -PET in the Management of Pituitary Tumours
Condition: Pituitary Tumours
Intervention: Procedure: Gallium-68 DOTATOC PET
3 Not yet recruiting Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors
Conditions: Pituitary Tumor;   ACTH-producing Pituitary Tumour
Intervention: Drug: Pasireotide LAR
4 Completed Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Pituitary Tumors
Condition: Pituitary Tumors
Intervention: Drug: Technetium Tc 99m EC20
5 Recruiting PITUItary Carcinoma or Aggressive Tumors REgistry -Lyon
Condition: Pituitary Tumor
Intervention:
6 Unknown  The Observational Study of Growth Hormone-secreting Pituitary Tumors
Conditions: Acromegaly;   Pituitary Tumor
Intervention:
7 Completed Follow-up Evaluation of Photo-Dynamic Therapy for Pituitary Tumours
Condition: Pituitary Neoplasms
Intervention:
8 Completed Calcium Homeostasis in Acromegaly: Effect of Surgical/Medical Treatment and Comparison With Nonfunctioning Pituitary Tumors
Conditions: Acromegaly;   Nonfunctioning Pituitary Tumor
Intervention:
9 Withdrawn Temozolomide in Treating Patients With Invasive Pituitary Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Genetic: DNA methylation analysis;   Genetic: microarray analysis;   Genetic: protein expression analysis;   Genetic: proteomic profiling;   Other: laboratory biomarker analysis
10 Active, not recruiting Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors
Conditions: Pituitary Tumor;   Pain
Interventions: Drug: IV Caldolor (IV Ibuprofen);   Drug: IV Ibuprofen placebo
11 Recruiting Effects of Total Intravenous Anesthesia With Propofol-remifentanil Versus Inhalational Anesthesia With Sevoflurane on Quality of Recovery in Patients Undergoing Transsphenoidal Surgery for Pituitary Tumor
Condition: Pituitary Tumor
Interventions: Drug: total intravenous anesthesia (TIVA);   Drug: inhalation anesthesia group
12 Recruiting Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy
Conditions: Pituitary Adenomas;   Prolactinomas
Intervention: Drug: Lapatinib
13 Recruiting An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
Conditions: Abnormalities;   Craniopharyngioma;   Cushing's Syndrome;   Endocrine Disease;   Pituitary Neoplasm
Intervention:
14 Active, not recruiting Identification of GENEtic Markers of Aggressiveness and Malignancy by Array Comparative Genomic Hybrization Analysis (CGH)
Condition: Pituitary Tumors
Intervention:
15 Terminated
Has Results
Rosiglitazone in Treating Patients With Pituitary Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: rosiglitazone maleate
16 Recruiting Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery
Condition: Pituitary Neoplasms
Interventions: Drug: Dexmedetomidine;   Drug: Sodium Chloride 0.9%
17 Terminated
Has Results
Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
Condition: Cushing's Disease
Intervention: Drug: rosiglitazone maleate
18 Unknown  Genome-wide Association Study of Pituitary Tumors
Condition: Pituitary Adenomas
Intervention:
19 Unknown  The Predictive Factors of Vision Recovery in Patients With Pituitary Tumor
Condition: Pituitary Adenomas
Intervention:
20 Completed Study of Cabergoline in Treatment of Corticotroph Pituitary Tumor
Conditions: Cushing's Disease;   Corticotroph Adenoma
Intervention: Drug: Cabergoline

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.